Skip to main content
Clinical Trials/NCT01726673
NCT01726673
Completed
Phase 2

Effects of Transcranial Direct Current Stimulation Paired With Robotic Arm Therapy on Recovery of Upper Extremity Motor Function in Stroke Patients

Northwell Health1 site in 1 country54 target enrollmentSeptember 2012
ConditionsStroke

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Stroke
Sponsor
Northwell Health
Enrollment
54
Locations
1
Primary Endpoint
Median Change in Upper Extremity Fugl Meyer Assessment Score
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study is to evaluate if multiple therapy sessions of Transcranial Direct Current Stimulation (tDCS non-invasive brain stimulation) combined with robotic arm therapy lead to a greater functional recovery in upper limb mobility after stroke than that provided by robotic arm therapy alone.

Registry
clinicaltrials.gov
Start Date
September 2012
End Date
June 2018
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Bruce Volpe

Principal Investigator

Northwell Health

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • First single focal unilateral lesion with diagnosis verified by brain imaging, which occurred at least 6 months prior
  • Cognitive function sufficient enough to understand experiments and follow instructions
  • Fugl-Meyer assessment of 7 to 58 out of 66 (neither hemiplegic nor fully recovered motor function in the muscles of the shoulder, elbow, and wrist)

Exclusion Criteria

  • Botox treatment within 6 weeks of enrollment
  • Fixed contraction of the affected limb
  • Complete flaccid paralysis of the affected limb
  • History of hemorrhagic stroke
  • Ongoing use of CNS active medications
  • Ongoing use of psychoactive medications
  • Presence of additional potential tDCS/TMS risk factors including damaged skin at site of stimulation, presence of a magnetically/mechanically active implant, metal in the head, family history of epilepsy, and personal history of seizures

Outcomes

Primary Outcomes

Median Change in Upper Extremity Fugl Meyer Assessment Score

Time Frame: baseline, discharge at 12 weeks (immediately following the intervention), and follow-up at 36 weeks (6 months after the intervention)

The median change in Upper Extremity Fugl-Meyer Score was calculated from baseline to discharge at 12 weeks (immediately following the intervention) and again at 36 weeks (6 months follow-up from the intervention) in each training condition (sham tDCS + robotics arm training vs. active tDCS + robotic arm training). The total Upper Extremity Fugl Meyer score is reported, with a range 0-66 points, and with higher values indicating better functional status.

Secondary Outcomes

  • Median Change in WOLF Motor Function Test (WMFT)(baseline, discharge at 12 weeks (immediately following the intervention), and follow-up at 36 weeks (6 months after the intervention))
  • Median Change in Motor Power Manual Muscle Test Score for the Upper Extremity (MRC)(12 weeks (immediately following the intervention) and 36 weeks (6 months after the intervention))

Study Sites (1)

Loading locations...

Similar Trials